Lung cancer classification: Difference between revisions
Trushatank (talk | contribs) |
No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Primary lung cancers may be classified into [[small cell lung cancer]] (~15%) and [[non small cell lung cancer]] (~85%). [[Non small cell lung cancer]] are a | Primary lung cancers may be [[Classification|classified]] into [[small cell lung cancer]] (~15%) and [[non small cell lung cancer]] (~85%). [[Non small cell lung cancer]] are a [[heterogeneous]] group of lung cancers that are often grouped together because they share similar clinical features (e.g. [[prognosis]] and management). The 2015 [[World Health Organization|WHO]] [[Histology|histological]] [[classification]] of [[tumors]] of the [[lung]] categorized [[lung]] [[tumors]] into [[malignant]] [[epithelial]] [[tumors]], [[benign]] [[epithelial]] [[tumors]], [[Lymphoproliferative disorders|lymphoproliferative tumors]], miscellaneous [[tumors]], and [[metastatic]] [[tumors]]. | ||
==Classification== | ==Classification== | ||
Primary lung cancers may be classified into two main categories:<ref name="WHO">{{cite book | last = Travis | first = William | title = Pathology and genetics of tumours of the lung, pleura, thymus, and heart | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 9283224183 }}</ref> | Primary lung cancers may be [[Classification|classified]] into two main categories:<ref name="WHO">{{cite book | last = Travis | first = William | title = Pathology and genetics of tumours of the lung, pleura, thymus, and heart | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 9283224183 }}</ref> | ||
*[[Small cell lung cancer]] (~15%) | *[[Small cell lung cancer]] (~15%) | ||
*[[Non small cell lung cancer]] (~85%). | *[[Non small cell lung cancer]] (~85%). | ||
Line 30: | Line 30: | ||
==WHO Histological Classification of Tumors of the Lung == | ==WHO Histological Classification of Tumors of the Lung == | ||
The [[World Health Organization]] ([[World Health Organization|WHO]]) classifies [[tumors]] of the [[lungs]] as follows:<ref name="WHO">{{cite book | last = Travis | first = William | title = Pathology and genetics of tumours of the lung, pleura, thymus, and heart | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 9283224183 }}</ref><ref name="urlwww.jto.org">{{cite web |url=https://www.jto.org/article/S1556-0864(15)33571-1/pdf |title=www.jto.org |format= |work= |accessdate=}}</ref> | The [[World Health Organization]] ([[World Health Organization|WHO]]) [[Classification|classifies]] [[tumors]] of the [[lungs]] as follows:<ref name="WHO">{{cite book | last = Travis | first = William | title = Pathology and genetics of tumours of the lung, pleura, thymus, and heart | publisher = IARC Press | location = Lyon | year = 2004 | isbn = 9283224183 }}</ref><ref name="urlwww.jto.org">{{cite web |url=https://www.jto.org/article/S1556-0864(15)33571-1/pdf |title=www.jto.org |format= |work= |accessdate=}}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 43: | Line 43: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adenocarcinoma of the lung|'''Adenocarcinoma''']] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adenocarcinoma of the lung|'''Adenocarcinoma''']] | ||
| | | | ||
* Lepidic adenocarcinoma | *[[Lepidic adenocarcinoma of the lung|Lepidic adenocarcinoma]] | ||
* Acinar adenocarcinoma | *[[Acinar adenocarcinoma of the lung|Acinar adenocarcinoma]] | ||
* Papillary adenocarcinoma | *[[Papillary adenocarcinoma of the lung|Papillary adenocarcinoma]] | ||
* Micropapillary adenocarcinoma | *[[Micropapillary adenocarcinoma of the lung|Micropapillary adenocarcinoma]] | ||
* Solid adenocarcinoma | *[[Solid adenocarcinoma of the lung|Solid adenocarcinoma]] | ||
* Invasive mucinous adenocarcinoma | *[[Invasive mucinous adenocarcinoma of the lung|Invasive mucinous adenocarcinoma]] | ||
** Mixed invasive mucinous | ** Mixed invasive mucinous | ||
** Nonmucinous adenocarcinoma | ** Nonmucinous adenocarcinoma | ||
* Colloid adenocarcinoma | *[[Colloid adenocarcinoma of the lung|Colloid adenocarcinoma]] | ||
* Fetal adenocarcinoma | *[[Fetal adenocarcinoma of the lung|Fetal adenocarcinoma]] | ||
* Enteric adenocarcinoma | *[[Enteric adenocarcinoma of the lung|Enteric adenocarcinoma]] | ||
* Minimally invasive adenocarcinoma | *[[Minimally invasive adenocarcinoma of the lung|Minimally invasive adenocarcinoma]] | ||
* Nonmucinous | ** Nonmucinous | ||
** Mucinous | ** Mucinous | ||
* | * Pre-[[Invasive (medical)|invasive]] [[Lesion|lesions]] | ||
** Atypical adenomatous hyperplasia | **[[Atypical adenomatous hyperplasia of the lung|Atypical adenomatous hyperplasia]] | ||
** Adenocarcinoma in situ | **[[Adenocarcinoma of the lung|Adenocarcinoma]] in situ | ||
*** Nonmucinous | *** Nonmucinous | ||
*** Mucinous | *** Mucinous | ||
Line 68: | Line 68: | ||
* Nonkeratinizing squamous cell carcinoma | * Nonkeratinizing squamous cell carcinoma | ||
* Basaloid squamous cell carcinoma | * Basaloid squamous cell carcinoma | ||
* | * Pre-[[Invasive (medical)|invasive]] [[lesion]] | ||
** Squamous cell carcinoma in situ | ** Squamous cell carcinoma in situ | ||
|- | |- | ||
Line 75: | Line 75: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell carcinoma of the lung|Small cell carcinoma]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell carcinoma of the lung|Small cell carcinoma]]''' | ||
| | | | ||
* Combined small cell carcinoma | * Combined [[Small cell carcinoma of lung|small cell carcinoma]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Large cell neuroendocrine carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Large cell neuroendocrine carcinoma of the lung|Large cell neuroendocrine carcinoma]]''' | ||
| | | | ||
* Combined large cell neuroendocrine carcinoma | * Combined [[Large cell neuroendocrine carcinoma of the lung|large cell neuroendocrine carcinoma]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Carcinoid syndrome|Carcinoid tumors]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Carcinoid syndrome|Carcinoid tumors]]''' | ||
| | | | ||
* Typical carcinoid tumor | *[[Carcinoid tumor|Typical carcinoid tumor]] | ||
* Atypical carcinoid tumor | *[[Carcinoid tumor|Atypical carcinoid tumor]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pre-[[Invasive (medical)|invasive]] [[lesion]]''' | ||
| | | | ||
* Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia | *[[Diffuse]] [[idiopathic]] [[Lung|pulmonary]] [[neuroendocrine cell]] [[hyperplasia]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Large cell carcinoma of the lung|Large cell carcinoma]]''' | ||
Line 94: | Line 94: | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Adenosquamous carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Adenosquamous carcinoma]]''' | ||
| | | | ||
* N/A | * N/A | ||
Line 100: | Line 100: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Sarcomatoid carcinoma of the lung|Sarcomatoid carcinomas]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Sarcomatoid carcinoma of the lung|Sarcomatoid carcinomas]]''' | ||
| | | | ||
* Pleomorphic carcinoma | *[[Pleomorphic carcinoma of the lung|Pleomorphic carcinoma]] | ||
* Spindle cell carcinoma | *[[Spindle cell carcinoma of the lung|Spindle cell carcinoma]] | ||
* Giant cell carcinoma | *[[Giant cell carcinoma of the lung|Giant cell carcinoma]] | ||
* Carcinosarcoma | *[[Carcinosarcoma of the lung|Carcinosarcoma]] | ||
* Pulmonary blastoma | *[[Pulmonary blastoma of the lung|Pulmonary blastoma]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Other and Unclassified carcinomas''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Other and [[Classification|Unclassified]] [[Carcinoma|carcinomas]]''' | ||
| | | | ||
* Lymphoepithelioma-like carcinoma | *[[Lymphoepithelioma-like carcinoma of the lung|Lymphoepithelioma-like carcinoma]] | ||
* NUT carcinoma | * NUT carcinoma | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Salivary gland-type tumors''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Salivary gland]]-type [[Tumor|tumors]]''' | ||
| | | | ||
* Mucoepidermoid carcinoma | *[[Mucoepidermoid carcinoma]] | ||
* Adenoid cystic carcinoma | * Adenoid cystic carcinoma | ||
* Epithelial-myoepithelial carcinoma | *[[Epithelium|Epithelial]]-[[myoepithelial]] [[carcinoma]] | ||
* Pleomorphic adenoma | *[[Pleomorphic adenoma]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Papillomas''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Papilloma|Papillomas]]''' | ||
| | | | ||
* Squamous cell papilloma | *[[Squamous cell papilloma]] | ||
** Exophytic | ** Exophytic | ||
** Inverted | ** Inverted | ||
* Glandular papilloma | *[[Gland|Glandular]] [[papilloma]] | ||
* Mixed squamous and glandular papilloma | * Mixed [[squamous]] and [[Gland|glandular]] [[papilloma]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Adenomas''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Adenoma|Adenomas]]''' | ||
| | | | ||
* Sclerosing pneumocytoma | * Sclerosing pneumocytoma | ||
* Alveolar adenoma | *[[Alveolar]] [[adenoma]] | ||
* Papillary adenoma | *[[Papilla|Papillary]] [[adenoma]] | ||
* Mucinous cystadenoma | *[[Mucinous cystadenoma]] | ||
* Mucous gland adenoma | *[[Mucous gland]] [[adenoma]] | ||
|- | |- | ||
! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Mesenchymal tumors''' | ! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Mesenchymal tumors''' | ||
Line 140: | Line 140: | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Chondroma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Chondroma]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''PEComatous tumors''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[PEComa|PEComatous tumors]]''' | ||
| | | | ||
* [[Lymphangiomyomatosis|Lymphangioleiomyomatosis]] | * [[Lymphangiomyomatosis|Lymphangioleiomyomatosis]] | ||
* [[PEComa]] | * [[PEComa]] (benign) | ||
** Clear cell tumor | **[[Clear cell tumor]] | ||
* PEComa | *[[PEComa]] ([[malignant]]) | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Congenital peribronchial myofibroblastic tumor''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Congenital peribronchial myofibroblastic tumor''' | ||
Line 155: | Line 155: | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse pulmonary lymphangiomatosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse [[Lung|pulmonary]] [[lymphangiomatosis]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Inflammatory myofibroblastic tumor''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Inflammation|Inflammatory]] [[Myofibroblast|myofibroblastic]] [[tumor]]''' | ||
| | | | ||
* N/A | * N/A | ||
Line 171: | Line 171: | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Synovial sarcoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Synovial sarcoma]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary artery intimal sarcoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pulmonary artery]] [[Tunica intima|intimal]] [[sarcoma]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary myxoid sarcoma with EWSR1–CREB1 translocation''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary myxoid sarcoma with EWSR1–CREB1 [[translocation]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | '''Myoepithelial tumors''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" | '''[[Myoepithelial]] [[Tumor|tumors]]''' | ||
| | | | ||
* Myoepithelioma | *[[Myoepithelial cells|Myoepithelioma]] | ||
* Myoepithelial carcinoma | *[[Myoepithelial]] [[carcinoma]] | ||
|- | |- | ||
! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Lymphohistiocytic tumors''' | ! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Lymphohistiocytic tumors''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Extranodal marginal zone lymphomas of mucosa-associated Lymphoid tissue (MALT lymphoma)''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Extranodal marginal zone lymphomas of [[MALT lymphoma|mucosa-associated Lymphoid tissue (MALT lymphoma)]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse large cell lymphoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Diffuse large cell [[lymphoma]]''' | ||
| | | | ||
* N/A | * N/A | ||
Line 202: | Line 202: | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Intravascular large B cell lymphoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Intravascular large [[B cell]] [[lymphoma]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pulmonary Langerhans cell histiocytosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lung|Pulmonary]] [[Langerhans cell histiocytosis]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Erdheim-Chester disease''' | ||
| | | | ||
* N/A | * N/A | ||
Line 216: | Line 216: | ||
! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Tumors of ectopic origin''' | ! colspan="2" style="background: #707070; color: #FFFFFF; text-align: center;" |'''Tumors of ectopic origin''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Germ cell tumors''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Germ cell tumor|Germ cell tumors]]''' | ||
| | | | ||
* | * Mature [[teratoma]] | ||
* | * Immature [[teratoma]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Intrapulmonary thymoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pulmonary|Intrapulmonary]] [[thymoma]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Melanoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Melanoma]]''' | ||
| | | | ||
* N/A | * N/A | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Meningioma, NOS''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Meningioma]], [[NOS]]''' | ||
| | | | ||
* N/A | * N/A |
Latest revision as of 18:12, 2 July 2019
Lung cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lung cancer classification On the Web |
American Roentgen Ray Society Images of Lung cancer classification |
Risk calculators and risk factors for Lung cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kim-Son H. Nguyen M.D. Cafer Zorkun, M.D., Ph.D. [2] Rim Halaby, M.D. [3] Dildar Hussain, MBBS [4]
Overview
Primary lung cancers may be classified into small cell lung cancer (~15%) and non small cell lung cancer (~85%). Non small cell lung cancer are a heterogeneous group of lung cancers that are often grouped together because they share similar clinical features (e.g. prognosis and management). The 2015 WHO histological classification of tumors of the lung categorized lung tumors into malignant epithelial tumors, benign epithelial tumors, lymphoproliferative tumors, miscellaneous tumors, and metastatic tumors.
Classification
Primary lung cancers may be classified into two main categories:[1]
- Small cell lung cancer (~15%)
- Non small cell lung cancer (~85%).
Lung Cancer | |||||||||||||||
Small cell lung cancer (~15%) | |||||||||||||||
Non small cell lung cancer (~85%)
| |||||||||||||||
WHO Histological Classification of Tumors of the Lung
The World Health Organization (WHO) classifies tumors of the lungs as follows:[1][2]
References
- ↑ 1.0 1.1 Travis, William (2004). Pathology and genetics of tumours of the lung, pleura, thymus, and heart. Lyon: IARC Press. ISBN 9283224183.
- ↑ "www.jto.org".